• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ENDOTAK RELIANCE S; DEFIBRILLATOR / PACEMAKER LEAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ENDOTAK RELIANCE S; DEFIBRILLATOR / PACEMAKER LEAD Back to Search Results
Device Problems Pacing Problem (1439); Impedance Problem (2950); High Capture Threshold (3266)
Patient Problems Muscle Weakness (1967); Dizziness (2194); Loss of consciousness (2418); Syncope/Fainting (4411)
Event Date 03/26/2023
Event Type  malfunction  
Event Description
It was reported that the patient with this unknown endotak right ventricular (rv) lead has had symptoms of dizziness and weakness as well as a recent syncopal episode.It was noted that high pacing thresholds and a gradual decrease in rv lead pacing impedance were observed.The patient has known atrial fibrillation (af) and had an atrioventricular (av) node ablation in the beginning of 2022.The patient is dependent on pacing therapy (100% vp).The device was reprogrammed to vvir mode to avoid potential av crosstalk, and technical services (ts) was consulted for further review.In office lead troubleshooting was recommended.No additional adverse patient effects were reported.
 
Manufacturer Narrative
This unknown lead remains implanted; therefore, technical analysis cannot be conducted.Without a returned product it is not possible to definitively confirm how it may have contributed to the complaint incident.If pertinent information is provided in the future, a supplemental report will be submitted.
 
Event Description
It was reported that the patient with this unknown endotak right ventricular (rv) lead has had symptoms of dizziness and weakness as well as a recent syncopal episode.It was noted that high pacing thresholds and a gradual decrease in rv lead pacing impedance were observed.The patient has known atrial fibrillation (af) and had an atrioventricular (av) node ablation in the beginning of 2022.The patient is dependent on pacing therapy (100% vp).The device was reprogrammed to vvir mode to avoid potential av crosstalk, and technical services (ts) was consulted for further review.In office lead troubleshooting was recommended.No additional adverse patient effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDOTAK RELIANCE S
Type of Device
DEFIBRILLATOR / PACEMAKER LEAD
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key16717947
MDR Text Key313107643
Report Number2124215-2023-16947
Device Sequence Number1
Product Code LWS
Combination Product (y/n)Y
Reporter Country CodeFR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/22/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/11/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/17/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-